Ultra Low Temperature Freezer Market

Ultra Low Temperature Freezer Market is Estimated to Witness High Growth Owing to Increased Research


An ultra-low temperature freezer, also known as ULT freezers or -80°C freezers, are used for high-volume storage of biospecimens, bio-samples, blood samples, vaccines and other biological reagents at temperatures below -70°C. ULT freezers are usually used for long-term storage of samples that need to be preserved at very low temperatures in laboratories, blood banks, hospitals and research organizations. The growing need to store temperature-sensitive samples such as stem cells, blood, and vaccines has been fueling the demand for ultra-low temperature freezers. Advancements in pharmaceutical and biotechnology sectors are also boosting the adoption of ULT freezers.

The Global Ultra Low Temperature Freezer Market is estimated to be valued at US$ 1,178.2 Mn in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the ultra low temperature freezer market are Thermo Fisher Scientific Inc., Haier Biomedical, PHC Corporation, Eppendorf SE, Jubilant HollisterStier, Helmer Scientific, Global Cooling Inc., Arctiko A/S, Bionics Scientific Technologies (P) Ltd., Esco Micro Pte. Ltd., Labcold Ltd., Azbil Telstar, S.L., BINDER GmbH, B Medical Systems, Glen Dimplex Group (Labcold), NuAire, Inc.

The key opportunities in the market include increasing demand from biobanks and biorepositories for long term storage of stem cells and other biological materials. Growing genomics sector and cell therapies will also present considerable growth prospects.

Technological advancements are focused on improving sample accessibility, controlled temperature during opening and closing of cabinet doors, and remote monitoring capabilities through Wi-Fi or Ethernet connectivity. Auto-programming features, touchscreens and large storage capacities are some other advanced features being offered.

Market drivers

The primary market driver is the rising research and development activities in pharmaceutical and life sciences industry. Ultra Low Temperature Freezer Market Growth in stem cell research, vaccine production, biobanking and clinical trials are directly fueling the demand for ULT freezers. Increasing food testing requirements are also propelling the market growth. Other factors such as rising healthcare investments, strict storage guidelines, and development of biosimilars and biologics are further augmenting the market expansion.

Current challenges in Ultra Low Temperature Freezer Market

The ultra low temperature freezer market is facing challenges due to rising cost of consumables such as liquid nitrogen and its transportation. Servicing and maintenance of these freezers also requires advanced technical skills adding to operational costs. Power consumption by ultra low temperature freezers is high adding pressures to energy budgets. Space constraint in laboratories and biobanks pose challenges for installation of large capacity freezers.

SWOT Analysis

Strength: Energy efficient models with increased storage capacities and advanced alarms/monitoring systems.

Weakness: High initial investment cost and dependence on liquid nitrogen for low temperature maintenance.

Opportunity: Growing biobanking industry and stem cell research generating demand. Adoption in developing countries offers scope.

Threats: Threat from substitute products providing similar functionality. Economic Slowdowns impacting research budget allocation.

Geographical regions with market concentration

North America accounts for the largest share of the ultra low temperature freezer market in terms of value owing to presence of major players and strong research funding. The U.S. represents the most lucrative market led by growing biobanking and stem cell research activities.

Fastest growing geographical region

Asia Pacific region is poised to witness highest growth during the forecast period owing to increasing healthcare expenditure, rising biomedical research projects and growing stem cell banking establishments especially in China and India. Initiatives to develop regional biobanks will support ultra low temperature freezer adoption.

1.  Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it